It was one of India’s strongest statements of the year for the pharmaceutical industry. The Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, has officially released the second call for applications under the Promotion of Research and Innovation in Pharma and MedTech (PRIP) Scheme \u2014 a \u20b95,000 crore government program aimed at boosting India’s pharmaceutical and medical device innovation ecosystem.<\/p>\n
According to News on AIR, this is a big turning point for entrepreneurs, MSMEs, Startups, and manufacturers in the pharma and MedTech industry. But the government is at the same time investing in the innovation pipeline of the Indian pharma industry by steering its companies to move up the innovation value chain \u2014 from generics to complex biologics, biosimilars, novel drug delivery systems and advanced medical devices.<\/p>\n
As a medical device innovator, formulation startup, medical devices business, or a pharma entrepreneur, this is not a policy you can afford to ignore. Applications will open around mid-September 2026. Time is brief. This is a huge opportunity.<\/p>\n